ArticleAsian Pacific journal of cancer prevention : APJCP2022

Possible Use of miR-223-3p as a Prognostic Marker in Transarterial Chemoembolization Treatment of Hepatocellular Carcinoma Patients.

Heba E Abdelaziz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.